Featured Research

from universities, journals, and other organizations

Survey Highlights Support For Nanotech In Health Fields But Disapproval Elsewhere

Date:
November 18, 2008
Source:
North Carolina State University
Summary:
A landmark national survey on the use of nanotechnology for "human enhancement" shows widespread public support for applications of the new technology related to improving human health. However, the survey also shows broad disapproval for nanotech human enhancement research in areas without health benefits.

A landmark national survey on the use of nanotechnology for "human enhancement" shows widespread public support for applications of the new technology related to improving human health. However, the survey also shows broad disapproval for nanotech human enhancement research in areas without health benefits. A team of researchers at North Carolina State University and Arizona State University (ASU) conducted the study, which could influence the direction of future nanotechnology research efforts.

The "Public Awareness of Nanotechnology Study" is the first nationally representative survey to examine public opinion on the use of nanotechnology for human enhancement. The survey found significant support for enhancements that promise to improve human health. For example, 88 percent of participants were in favor of research for a video-to-brain link that would amount to artificial eyesight for the blind. However, there was little support for non-health research endeavors. For example, only 30 percent of participants approved of research into implants that could improve performance of soldiers on the battlefield.

Nanotechnology is generally defined as technology that uses substances having a size of 100 nanometers or less (tens of thousands of times smaller than the width of a human hair), and is expected to have widespread uses in medicine, consumer products and industrial processes. Human enhancement is a sweeping term that applies to the use of such technologies to alter human capabilities.

NC State's Dr. Michael Cobb, one of the leaders of the study, says the survey's findings are important because "what the public wants could drive the direction of future research." Cobb, an associate professor of political science, explains, "The public should have input into where the government invests its research funding." Dr. Clark Miller, an associate professor of political science at ASU and another leader of the survey, adds, "One of the most important findings is the difference in support for different applications of human enhancement. Research and public policies will need to reflect this differentiated view, recognizing that there are some applications the public supports and some that the public is quite skeptical of."

While the survey shows strong public support for research into nanotechnology applications in the health field, those findings are tempered by a similar concern from the public about the scope of that research. The study found that 55 percent of participants felt that researchers should "avoid playing God with new technologies." Similarly, the public expressed little confidence in the government and mass media to inform people about potential risks from new technologies. Rather, participants said they had the greatest confidence in university scientists and environmental groups to protect the public.

Leaders of the study were NC State's Cobb, ASU's Miller, Sean Hays, doctoral student in political science at ASU, and Dr. David Guston, professor of political science and director of the Center for Nanotechnology in Society at Arizona State University (CNS). The study was funded by CNS under a cooperative agreement from the National Science Foundation to conduct research, training and outreach on the societal aspects of nanotechnology. The study's findings complement earlier findings of the CNS National Citizens' Technology Forum, organized by Cobb and NC State researcher Dr. Patrick Hamlett in April 2008.

The survey was conducted between July and October of 2008. The survey included 556 participants, had a 28 percent response rate, and has a margin of error of plus or minus 4.1 percent.


Story Source:

The above story is based on materials provided by North Carolina State University. Note: Materials may be edited for content and length.


Cite This Page:

North Carolina State University. "Survey Highlights Support For Nanotech In Health Fields But Disapproval Elsewhere." ScienceDaily. ScienceDaily, 18 November 2008. <www.sciencedaily.com/releases/2008/11/081113100718.htm>.
North Carolina State University. (2008, November 18). Survey Highlights Support For Nanotech In Health Fields But Disapproval Elsewhere. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/11/081113100718.htm
North Carolina State University. "Survey Highlights Support For Nanotech In Health Fields But Disapproval Elsewhere." ScienceDaily. www.sciencedaily.com/releases/2008/11/081113100718.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins